Registration statement

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages LifeStance Health Group (LFST) Investors with Losses to Contact Firm’s Attorneys, Oct. 11th Deadline Approaching in Securities Class Action

Retrieved on: 
Sunday, October 2, 2022

SAN FRANCISCO, Oct. 02, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges LifeStance Health Group, Inc. (NASDAQ: LFST) investors with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Oct. 02, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges LifeStance Health Group, Inc. (NASDAQ: LFST) investors with significant losses to submit your losses now .
  • On Aug. 11, 2021, LifeStance reported Q2 2021 financial results.
  • On Nov. 8, 2021, LifeStance reported Q3 2021 financial results, disclosing [c]linician retention [had] stabilized to approximately 80% annualized in the third quarter.
  • Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.

UPCOMING TSP INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that TuSimple Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Retrieved on: 
Saturday, October 1, 2022

A lead plaintiff acts on behalf of all other class members in directing the TuSimple class action lawsuit.

Key Points: 
  • A lead plaintiff acts on behalf of all other class members in directing the TuSimple class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the TuSimple class action lawsuit.
  • An investors ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the TuSimple class action lawsuit.
  • ABOUT ROBBINS GELLER: Robbins Geller is one of the worlds leading complex class action firms representing plaintiffs in securities fraud cases.

ROSEN, A TOP RANKED LAW FIRM, Encourages Tuya Inc. Investors to Secure Counsel Before Important October 11 Deadline in Securities Class Action – TUYA

Retrieved on: 
Friday, September 30, 2022

WHAT TO DO NEXT: To join the Tuya class action, go to https://rosenlegal.com/submit-form/?case_id=7007 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Tuya class action, go to https://rosenlegal.com/submit-form/?case_id=7007 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Perfect Corp. and Provident Acquisition Corp. Announce Effectiveness of Registration Statement and Extraordinary General Meeting Date for Proposed Business Combination

Retrieved on: 
Friday, September 30, 2022

Provident will hold an extraordinary general meeting of its shareholders (the EGM) at 9:00 a.m. Eastern Time on October 25, 2022 to approve, among other things, the Business Combination.

Key Points: 
  • Provident will hold an extraordinary general meeting of its shareholders (the EGM) at 9:00 a.m. Eastern Time on October 25, 2022 to approve, among other things, the Business Combination.
  • Founded in 2015, Perfect is a global leader in providing AR and AI SaaS solutions to beauty and fashion industries.
  • Affiliated with Provident Capital, Provident is a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses.
  • Perfect and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the shareholders of Provident in connection with the Business Combination.

HGEN, CPNG & SFIX Class Actions: Bronstein, Gewirtz & Grossman, LLC, A Leading Class Action Firm, Reminds Investors to Contact the Firm and Actively Participate

Retrieved on: 
Friday, September 30, 2022

You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.

Key Points: 
  • You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at212-697-6484.
  • If you suffered a loss, you can request that the Court appoint you as lead plaintiff.
  • As a result of these misrepresentations and omissions, Stitch Fix's Class A common stock traded at artificially inflated prices during the Class Period.

Ecoark Holdings Reiterates Record Date for Stock Dividends for Recent White River and Banner Midstream Spin-off Transactions

Retrieved on: 
Friday, September 30, 2022

On July 25, 2022, Ecoark exchanged its common stock of White River Holdings Corp for $30,000,000 of convertible preferred stock of White River Energy Corp which recently changed its name from Fortium Holdings Corp (OTC: FRTM) (White River).

Key Points: 
  • On July 25, 2022, Ecoark exchanged its common stock of White River Holdings Corp for $30,000,000 of convertible preferred stock of White River Energy Corp which recently changed its name from Fortium Holdings Corp (OTC: FRTM) (White River).
  • Only September 6, 2022, Ecoark exchanged its common stock of Banner Midstream Corp (Banner) for 12,996,958 shares of Enviro Technologies US, Inc. (OTC: EVTN) (Enviro) common stock.
  • Assuming this timeline is met, Ecoark projects the record date for the Zest stock dividend will be November 15, 2022, close of business.
  • White River owns White River Holdings Corp., an oil and gas drilling, exploration, and production company.

CENTESSA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Centessa Pharmaceuticals Plc and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, September 30, 2022

Investors have until November 28, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until November 28, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Centessa is a clinical-stage pharmaceutical company that purports to discover, develop, and deliver medicines to patients.
  • Additionally, throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and prospects.
  • As of the time the complaint was filed, Centessas ADS price continues to trade significantly below the $20.00 per ADS Offering price, damaging investors.

CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Centessa Pharmaceuticals plc (NASDAQ: CNTA)

Retrieved on: 
Thursday, September 29, 2022

NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired: (a) Centessa Pharmaceuticals plc (“Centessa” or the “Company”) (NASDAQ: CNTA) American Depositary Shares (“ADSs”) pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about May 28, 2021 (the “IPO” or “Offering”); and/or (b) Centessa securities between May 28, 2021 and June 1, 2022, both dates inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Central District of California and alleges violations of the Securities Act of 1933 and Securities Exchange Act of 1934.

Key Points: 
  • If so, please visit Centessa Pharmaceuticals plc Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Centessa is a clinical-stage pharmaceutical company that purports to discover, develop, and deliver medicines to patients.
  • Plaintiff alleges that Defendants made materially false and misleading statements in the Offering Documents and throughout the Class Period.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Pay Off of Remaining Balance of its Senior Secured Notes

Retrieved on: 
Thursday, September 29, 2022

Scilex is a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, Sorrento).

Key Points: 
  • Scilex is a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, Sorrento).
  • The boards of directors of each of Vickers, Scilex and Sorrento have unanimously approved the proposed transaction.
  • Scilex targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with moderate to severe pain.
  • Scilex Holding Company is headquartered in Palo Alto, California, with operations in both Palo Alto and San Diego, California.

FiscalNote Files Amendment to Its Previously Filed Form S-1 Registration Statement

Retrieved on: 
Thursday, September 29, 2022

FiscalNote (NYSE: NOTE), a leading AI-driven enterprise SaaS company that delivers market intelligence and data insights, today announced it has filed an amendment to the resale registration statement on Form S-1 (the Registration Statement) that the Company previously filed with the U.S. Securities & Exchange Commission (the SEC) on August 26, 2022.

Key Points: 
  • FiscalNote (NYSE: NOTE), a leading AI-driven enterprise SaaS company that delivers market intelligence and data insights, today announced it has filed an amendment to the resale registration statement on Form S-1 (the Registration Statement) that the Company previously filed with the U.S. Securities & Exchange Commission (the SEC) on August 26, 2022.
  • The Company amended the Registration Statement to respond to comments from the SEC staff in connection with its ordinary review process.
  • The Registration Statement has been filed with the SEC but has not yet become effective.
  • The securities covered by the Registration Statement may not be sold nor may offers to buy be accepted before the Registration Statement becomes effective.